フェニレフリン製剤の世界市場

フェニレフリン製剤の世界市場は2030年までに330億米ドルに達する見込み

2024年に229億米ドルと推定されるフェニレフリン製剤の世界市場は、2024年から2030年にかけてCAGR 6.3%で成長し、2030年には330億米ドルに達すると予測されます。本レポートで分析したセグメントの一つである錠剤は、CAGR7.0％を記録し、分析期間終了時には149億米ドルに達すると予測されます。シロップ剤セグメントの成長率は、分析期間中CAGR 6.8％と推定されます。

米国市場は62億米ドルと推定、中国はCAGR 10.0％で成長予測

米国のフェニレフリン製剤市場は2024年に62億米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 10.0％を辿り、2030年までに68億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.1%と6.2%と予測されています。欧州では、ドイツがCAGR 4.1%で成長すると予測されています。

世界のフェニレフリン製剤市場- 主要動向と促進要因まとめ

フェニレフリンは長年市場に存在するにもかかわらず、なぜ再注目されているのか？

選択的α1アドレナリン受容体作動薬であるフェニレフリンは、何十年もの間、一般用医薬品（OTC）および処方薬の主力品であり、主に鼻の充血除去剤、血管圧降下剤、散瞳剤として使用されてきました。その魅力は血管収縮作用にあり、鼻づまりを解消し、低血圧患者の血圧を上げ、眼科検査を容易にします。その長い市場の歴史にもかかわらず、フェニレフリン製剤は、進化する規制当局の動き、製剤の革新、小売と病院の両方における需要の変化により、再吟味され、市場での位置づけが見直されています。

規制当局、特に米国FDAが、経口投与のフェニレフリンの鼻づまり改善効果に疑問を呈したことが大きな転換点となりました。これをきっかけに、メーカー各社は製剤改良の波に乗り、より優れたバイオアベイラビリティを提供する鼻腔内スプレー、点眼液、注射剤などの代替投与形態の開発に拍車をかけた。病院では、特に麻酔時や敗血症性ショック時の低血圧に対する即効性の血管圧降下薬として、フェニレフリンの静脈内投与が引き続き信頼されており、臨床的意義が持続しています。

さらに、眠くならない風邪薬やインフルエンザ治療薬へのシフトにより、フェニレフリンはプソイドエフェドリンを含まない選択肢として流通しています。この有効成分は、耳鼻咽喉科、眼科、クリティカルケアなどの用途に適応できるため、一般用医薬品の関連性が変動しているにもかかわらず、幅広い市場シェアを維持しています。

規制と再製剤化の動向は製品パイプラインをどのように形成しているか？

最近の規制動向は、特に経口充血除去剤セグメントにおけるフェニレフリンの位置づけに大きな影響を与えています。2023年の米国FDA諮問委員会は、経口フェニレフリンは標準的なOTC用量では効果がないと結論づけ、ラベル改訂や製品回収を求める声に火をつけた。フェニレフリンを主成分とする風邪薬をさまざまなブランド名で販売していた製薬会社では、この結果を受けて、製剤の改良が進められています。

この開発はOTC領域に課題を投げかけているが、同時に、肝代謝を迂回し、より効果的な血漿中濃度を達成する経鼻・非経口製剤に業界の焦点を移しつつあります。製薬会社は、フェニレフリンとコルチコステロイドや抗ヒスタミン剤を組み合わせて副鼻腔を緩和する点鼻薬や併用鼻腔内療法をますます重視するようになっています。これと並行して、ジェネリック医薬品メーカー各社は、特に手術室やICUの管理という観点から、病院調達用の注射用フェニレフリンの生産を強化しています。

眼科領域では、フェニレフリンは依然として瞳孔拡張の標準薬であり、しばしばトロピカミドと組み合わせて点眼されます。製剤の改良により、保存性が向上し、チクチク感が減少し、周囲条件下での安定性が確保されつつあります。これらの進歩は、消費者向けの製剤が移行しつつある中でも、規制された臨床環境におけるフェニレフリンのライフサイクルの延長に役立っています。

どの治療セグメントと世界市場が需要を牽引しているか？

フェニレフリンの有用性は、呼吸ケア、クリティカルケア（血管圧迫薬）、眼科の3つの中心的な治療領域にわたっています。呼吸器領域では、作用発現が早く全身吸収が少ない点から、経鼻投与が人気を集めています。経口フェニレフリンの市場シェアは低下しているもの、アレルギー、副鼻腔炎、季節性インフルエンザの市場では、点鼻薬とネブライザーによる需要は比較的安定しています。

病院環境では、フェニレフリン注射は周術期の低血圧や敗血症性ショックの管理に広く使用されています。標準化された麻酔プロトコールに含まれ、プレフィルドシリンジやアンプルで迅速に入手できることから、救急医療や手術管理に不可欠な要素となっています。新興国における入院率の上昇とICUの拡張が、無菌注射用フェニレフリンの需要をさらに押し上げています。

地域的には、北米が病院インフラの規模やOTCユーザーの基盤が確立していることから優位を占めています。欧州は、特に眼科用途と重篤な治療環境において僅差で続いています。アジア太平洋市場では、国家調達プログラム、医療インフラの整備、ジェネリックメーカーによる現地生産の拡大により、フェニレフリンの使用が伸びています。インドや中国のような国も主要なフェニレフリン原薬供給国になりつつあり、世界のサプライチェーンと価格設定に影響を与えています。

世界フェニレフリン製剤市場の成長を牽引するものは何か？

フェニレフリン製剤の世界市場成長の原動力は、注射用血管圧迫薬に対する病院需要の増加、眼科用薬剤ポートフォリオの拡大、鼻腔充血除去薬の再製剤化、外科手術やクリティカルケア環境における持続的有用性です。規制の精査はOTC状況を再構築しているが、同時に処方薬や施設でのフェニレフリンの価値を強化しています。

病院の拡張、麻酔中の低血圧エピソードの増加率、ICU入室の増加などが、フェニレフリンのような信頼性の高い血管圧降下薬への需要を煽っています。一方、目の検査や手術における瞳孔拡張剤の継続的な需要が、眼科での使用を支えています。メーカー各社は、実用性を高めるため、防腐剤無添加の単位用量バイアルや配合剤などの新しい剤形で対応しています。

さらに、フェニレフリンの原薬製造基盤は強固でコスト競争力があるため、製剤メーカーは市場力学の変化に迅速に対応することができます。経口OTC製品における課題にもかかわらず、この原薬は規制と臨床の両方の期待に応えるフォーマットで再配置されつつあります。ドラッグデリバリーの最適化とクリティカルケア医薬品への世界アクセスへの注目が高まる中、フェニレフリン製剤市場は継続的な適応と回復の態勢を整えています。

セグメント

タイプ（錠剤、シロップ、点眼薬、その他のタイプ）、適応症（風邪の適応症、鼻の充血除去の適応症、アレルギー反応の適応症、眼疾患の適応症、その他の適応症）、投与経路（経口投与、非経口投与、その他の投与経路）、流通チャネル（病院薬局、ドラッグストア・小売薬局、オンライン流通チャネル）

調査対象企業の例

• Aarti Pharmalabs Limited
• Alembic Pharmaceuticals Ltd.
• Bayer AG
• Boehringer Ingelheim GmbH
• Cadila Pharmaceuticals
• Divi's Laboratories Limited
• Dr. Reddy's Laboratories
• Fagron Sterile Services
• Foundation Consumer Brands LLC
• GlaxoSmithKline plc
• Hikma Pharmaceuticals plc
• Merck & Co., Inc.
• Mylan N.V.（Viatris）
• Novartis AG
• Perrigo Company plc
• Pfizer Inc.
• Procter & Gamble Co.
• Sanofi S.A.
• Torrent Pharmaceuticals Inc.
• Wockhardt Ltd.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Phenylephrine Drugs Market to Reach US$33.0 Billion by 2030

The global market for Phenylephrine Drugs estimated at US$22.9 Billion in the year 2024, is expected to reach US$33.0 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Tablets, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$14.9 Billion by the end of the analysis period. Growth in the Syrup segment is estimated at 6.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.2 Billion While China is Forecast to Grow at 10.0% CAGR

The Phenylephrine Drugs market in the U.S. is estimated at US$6.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.8 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Phenylephrine Drugs Market - Key Trends & Drivers Summarized

Why Is Phenylephrine Seeing Renewed Interest Despite Its Longstanding Market Presence?

Phenylephrine, a selective α1-adrenergic receptor agonist, has been a mainstay in over-the-counter (OTC) and prescription drugs for decades, primarily used as a nasal decongestant, vasopressor, and mydriatic agent. Its appeal lies in its vasoconstrictive properties, which enable it to relieve nasal congestion, raise blood pressure in hypotensive patients, and facilitate ophthalmic examinations. Despite its long market history, phenylephrine drugs are undergoing renewed scrutiny and market repositioning due to evolving regulatory actions, formulation innovations, and demand shifts in both retail and hospital settings.

A major inflection point occurred when regulatory bodies, particularly the U.S. FDA, questioned the efficacy of orally administered phenylephrine for nasal decongestion. This has triggered a wave of reformulation activity among manufacturers and catalyzed the development of alternative delivery formats, such as intranasal sprays, ophthalmic solutions, and injectable formulations that offer better bioavailability. Hospitals continue to rely on intravenous phenylephrine as a fast-acting vasopressor for hypotension, especially during anesthesia or septic shock, ensuring sustained clinical relevance.

Additionally, the shift toward non-drowsy cold and flu medications has kept phenylephrine in circulation as a pseudoephedrine-free option, especially in regions where regulatory restrictions on pseudoephedrine sales remain stringent. The active ingredient's adaptability across ENT, ophthalmic, and critical care applications helps maintain a broad market footprint, despite fluctuating OTC relevance.

How Are Regulatory and Reformulation Trends Reshaping Product Pipelines?

Recent regulatory developments have deeply impacted the positioning of phenylephrine, particularly in the oral decongestant segment. A U.S. FDA advisory panel in 2023 concluded that oral phenylephrine is ineffective at standard OTC doses, sparking calls for label revisions and product withdrawals. This finding is driving a reformulation push among pharmaceutical companies that had previously marketed phenylephrine-based cold medications under various brand names.

While this development challenges the OTC space, it is also redirecting industry focus toward intranasal and parenteral formulations that bypass hepatic metabolism and achieve more effective plasma concentrations. Pharmaceutical companies are increasingly emphasizing nasal sprays and combination intranasal therapies that pair phenylephrine with corticosteroids or antihistamines for dual-action sinus relief. In parallel, generic drug makers are ramping up production of injectable phenylephrine for hospital procurement, especially in the context of operating room and ICU management.

In ophthalmology, phenylephrine remains a gold-standard agent for pupil dilation, often paired with tropicamide in combination drops. Formulation improvements are enhancing shelf life, reducing stinging sensation, and ensuring stability under ambient conditions. These advances are helping extend phenylephrine’s lifecycle in regulated clinical settings, even as its consumer-facing formulations undergo transition.

Which Therapeutic Segments and Global Markets Are Driving Demand?

Phenylephrine's utility spans three core therapeutic domains: respiratory care, critical care (vasopressors), and ophthalmology. In respiratory care, the intranasal segment is gaining traction due to fast onset of action and minimal systemic absorption. Despite the erosion of oral phenylephrine’s market share, demand remains relatively stable for nasal sprays and nebulized solutions in allergy, sinusitis, and seasonal flu markets.

In hospital settings, phenylephrine injections are widely used for managing perioperative hypotension and septic shock. Their inclusion in standardized anesthesia protocols, combined with rapid availability in prefilled syringes and ampoules, makes them a critical component of emergency care and surgical management. Increased hospitalization rates and ICU expansions in emerging economies are further boosting demand for sterile injectable phenylephrine.

Geographically, North America dominates due to the scale of hospital infrastructure and the established base of OTC users. Europe follows closely, especially in ophthalmic applications and critical care settings. Asia-Pacific markets are witnessing growth in phenylephrine use through national procurement programs, rising healthcare infrastructure, and expanded local production by generic manufacturers. Countries like India and China are also becoming major phenylephrine API suppliers, influencing global supply chains and pricing.

What Is Driving Growth in the Global Phenylephrine Drugs Market?

The growth in the global phenylephrine drugs market is driven by increasing hospital demand for injectable vasopressors, expanding ophthalmic drug portfolios, reformulation of nasal decongestants, and sustained utility in surgical and critical care environments. While regulatory scrutiny is reshaping the OTC landscape, it is simultaneously reinforcing phenylephrine’s value in prescription and institutional settings.

Hospital expansions, growing rates of hypotensive episodes during anesthesia, and rising ICU admissions are fueling demand for reliable vasopressors like phenylephrine. Meanwhile, continued demand for pupil-dilating agents in eye exams and surgeries is sustaining its use in ophthalmology. Manufacturers are responding with new formats such as preservative-free, unit-dose vials and combination formulations for enhanced utility.

Additionally, the API manufacturing base for phenylephrine is strong and cost-competitive, allowing formulators to adapt quickly to changing market dynamics. Despite challenges in oral OTC products, the active pharmaceutical ingredient is being repositioned across formats that meet both regulatory and clinical expectations. With a growing focus on drug delivery optimization and global access to critical care drugs, the phenylephrine drugs market is poised for continued adaptation and resilience.

SCOPE OF STUDY:

The report analyzes the Phenylephrine Drugs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Tablets, Syrup, Eye Drops, Other Types); Indication (Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication, Other Indications); Administration Route (Oral Administration, Parenteral Administration, Other Administration Routes); Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Aarti Pharmalabs Limited
• Alembic Pharmaceuticals Ltd.
• Bayer AG
• Boehringer Ingelheim GmbH
• Cadila Pharmaceuticals
• Divi's Laboratories Limited
• Dr. Reddy's Laboratories
• Fagron Sterile Services
• Foundation Consumer Brands LLC
• GlaxoSmithKline plc
• Hikma Pharmaceuticals plc
• Merck & Co., Inc.
• Mylan N.V. (Viatris)
• Novartis AG
• Perrigo Company plc
• Pfizer Inc.
• Procter & Gamble Co.
• Sanofi S.A.
• Torrent Pharmaceuticals Inc.
• Wockhardt Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Phenylephrine Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Regulatory Scrutiny Over Oral Decongestants Throws the Spotlight On Phenylephrine Formulations
  • Shifting Clinical Preferences Toward Safer Nasal Agents Drives Demand for Topical Phenylephrine
  • Increased Incidence of Allergic Rhinitis and Sinusitis Spurs Use of Sympathomimetic Agents
  • Rising OTC Sales of Cold and Flu Remedies Expands Addressable Market for Phenylephrine-Based Products
  • Debate Over Oral Bioavailability Strengthens Business Case for Reformulated and Nasal Delivery Formats
  • Surge in Pediatric Respiratory Infections Drives Use of Low-Dose Phenylephrine Syrups
  • Stringent FDA and EMA Guidelines on Efficacy Drive R&D in Improved Phenylephrine Delivery Systems
  • Growing Availability of Combination Therapy Products Enhances Market Penetration
  • Hospital Demand for Hemodynamic Stabilization Agents Spurs Use of Injectable Phenylephrine
  • Public Health Campaigns Around Self-Medication Increase Demand for Non-Prescription Decongestants
  • Increased Generic Competition Creates Pressure on Pricing and Innovation in Differentiated Formulations
  • Expansion of E-Commerce and D2C Pharmacies Drives Online Sales of Phenylephrine Products
  • Seasonal Demand Spikes During Allergy and Flu Seasons Sustain Growth in Decongestant Categories
  • Reformulation of Cough-Cold Products in Response to Regulatory Reviews Drives Product Redevelopment
  • Increased Focus on Abuse-Deterrent Formulations Promotes Safer Phenylephrine Combinations
  • Rising Demand for Single-Ingredient Nasal Sprays Fuels Product Line Diversification
  • Emergence of Novel Nasal Delivery Technologies Enhances Targeted Therapeutic Efficiency
  • Clinical Use in Managing Hypotension During Anesthesia Expands Hospital Market Opportunity
  • Regional Differences in Regulatory Classifications Create Market Entry Challenges and Opportunities
  • Increased Healthcare Provider Education on Dosing and Efficacy Supports Informed Prescribing Practices
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Phenylephrine Drugs Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Phenylephrine Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Phenylephrine Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Phenylephrine Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Tablets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Syrup by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Syrup by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Syrup by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Eye Drops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Eye Drops by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Eye Drops by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Other Administration Routes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Other Administration Routes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Drug Stores & Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Drug Stores & Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Drug Stores & Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Cold Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Cold Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Cold Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Nasal Decongestion Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Nasal Decongestion Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Nasal Decongestion Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Allergic Reaction Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Allergic Reaction Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Allergic Reaction Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Eye Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Eye Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Eye Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 50: USA Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: USA 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: USA 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: USA 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Canada 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Canada 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Canada 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• JAPAN
  • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Japan 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Japan 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Japan 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Japan 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• CHINA
  • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 86: China Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: China 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: China 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: China 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: China 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• EUROPE
  • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Phenylephrine Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Europe 16-Year Perspective for Phenylephrine Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Europe 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Europe 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Europe 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Europe 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• FRANCE
  • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 113: France Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: France 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: France 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: France 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 122: France Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: France 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• GERMANY
  • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Germany 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Germany 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Germany 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 134: Germany Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Germany Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Germany 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Italy 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Italy 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Italy 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 146: Italy Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Italy Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Italy 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 149: UK Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: UK 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: UK 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: UK 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 158: UK Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: UK Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: UK 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Spain 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Spain 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Spain 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 170: Spain Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Spain Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Spain 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Russia 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Russia 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Russia 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 182: Russia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Russia Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Russia 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Europe 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Phenylephrine Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Australia 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Australia 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Australia 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 221: Australia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Australia Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Australia 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• INDIA
  • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 224: India Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: India 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: India 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: India 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 233: India Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: India Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: India 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: South Korea 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: South Korea 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: South Korea 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: South Korea Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: South Korea 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Phenylephrine Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Latin America 16-Year Perspective for Phenylephrine Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Latin America 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Latin America 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Latin America 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Latin America 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Argentina 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Argentina 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Argentina 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Argentina Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Argentina 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Brazil 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Brazil 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Brazil 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Brazil Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Brazil 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Mexico 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Mexico 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Mexico 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Mexico Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Mexico 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Rest of Latin America 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Phenylephrine Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Middle East 16-Year Perspective for Phenylephrine Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Middle East 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Middle East 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Middle East 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Middle East 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Iran 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Iran 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Iran 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 347: Iran Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Iran Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Iran 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Israel 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Israel 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Israel 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 359: Israel Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Israel Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Israel 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: Saudi Arabia 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: UAE 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: UAE 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: UAE 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 383: UAE Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: UAE Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: UAE 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: Rest of Middle East 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030
• AFRICA
  • Phenylephrine Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Phenylephrine Drugs by Type - Tablets, Syrup, Eye Drops and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Africa 16-Year Perspective for Phenylephrine Drugs by Type - Percentage Breakdown of Value Sales for Tablets, Syrup, Eye Drops and Other Types for the Years 2014, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Phenylephrine Drugs by Administration Route - Oral Administration, Parenteral Administration and Other Administration Routes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 403: Africa 16-Year Perspective for Phenylephrine Drugs by Administration Route - Percentage Breakdown of Value Sales for Oral Administration, Parenteral Administration and Other Administration Routes for the Years 2014, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for Phenylephrine Drugs by Distribution Channel - Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 406: Africa 16-Year Perspective for Phenylephrine Drugs by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Drug Stores & Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
  • TABLE 407: Africa Recent Past, Current & Future Analysis for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Africa Historic Review for Phenylephrine Drugs by Indication - Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 409: Africa 16-Year Perspective for Phenylephrine Drugs by Indication - Percentage Breakdown of Value Sales for Cold Indication, Nasal Decongestion Indication, Allergic Reaction Indication, Eye Disease Indication and Other Indications for the Years 2014, 2025 & 2030

IV. COMPETITION